- ALK
inhibitors are anti-cancer
drugs that act on
tumours with
variations of
anaplastic lymphoma kinase (ALK) such as an EML4-ALK translocation. They fall...
- for
anemia Sotatercept (ACE-011) for
pulmonary arterial hypertension Dalantercept (ACE-041) for
kidney cancer ACE-083 for
muscular disorders The company...
- inhibitors: K-02288 ML-347 (LDN-193719, VU0469381)
Decoy receptors:
Dalantercept Other inhibitors:
Disitertide ALK2 (ACVR1A) Agonists:
Activin (A, B,...
- inhibitors: K-02288 ML-347 (LDN-193719, VU0469381)
Decoy receptors:
Dalantercept Other inhibitors:
Disitertide ALK2 (ACVR1A) Agonists:
Activin (A, B,...
- inhibitors: K-02288 ML-347 (LDN-193719, VU0469381)
Decoy receptors:
Dalantercept Other inhibitors:
Disitertide ALK2 (ACVR1A) Agonists:
Activin (A, B,...
- inhibitors: K-02288 ML-347 (LDN-193719, VU0469381)
Decoy receptors:
Dalantercept Other inhibitors:
Disitertide ALK2 (ACVR1A) Agonists:
Activin (A, B,...
- inhibitors: K-02288 ML-347 (LDN-193719, VU0469381)
Decoy receptors:
Dalantercept Other inhibitors:
Disitertide ALK2 (ACVR1A) Agonists:
Activin (A, B,...
- inhibitors: K-02288 ML-347 (LDN-193719, VU0469381)
Decoy receptors:
Dalantercept Other inhibitors:
Disitertide ALK2 (ACVR1A) Agonists:
Activin (A, B,...
- inhibitors: K-02288 ML-347 (LDN-193719, VU0469381)
Decoy receptors:
Dalantercept Other inhibitors:
Disitertide ALK2 (ACVR1A) Agonists:
Activin (A, B,...
- inhibitors: K-02288 ML-347 (LDN-193719, VU0469381)
Decoy receptors:
Dalantercept Other inhibitors:
Disitertide ALK2 (ACVR1A) Agonists:
Activin (A, B,...
